← All peptidesPDA-V1 attestation Citations
warningBioGate · AMBERGrade B
Octreotide (Sandostatin)
fCFwKTCT-olSynthetic octapeptide somatostatin analog; suppresses GH, insulin, glucagon, and gut peptides via SSTR2/SSTR5 binding.
D-Phe¹D-Trp⁴C-terminal threoninoldisulfide C2-C7
MW
1019.24
Length
11aa
Posterior
81.3%
Structural preview · ESMFold-2 mockdeterministic per sequence
Backbone preview · D-Phe¹
Cryptographic chain of custody.
- Outer PDA hash
- Inputs hash
- Merkle root
- TEE attestation
- Protocol version
- PDA-V1
- Source
- peptide-md
- Model version
- structure-fm-2026.04
- Candidates emitted
- 4
- Signed
- 2026-04-21T08:14:33Z
Verifiable in your browser at /verifier with
@peptide-md/verifier.Real-world evidence
Cohort-attested outcomes.
Cohorts
7
Participants
115
Mean Δ
+5.7
Δ HRV ms (8-week) · 95% CI [4.75, 6.64]
IPNFT · Molecule IPNFT V2Solana
Octreotide (Sandostatin)
91100d…ad9410Royalty cascade
13.64%
Holders
92
Royalty cascade routes lab fees, licensing, and OEA-attested cohort revenues back to holders, the cohort treasury, and the originating researchers in a 60 / 25 / 15 split.